CSL BEHRING UK LIMITED

1. CSL BEHRING UK LIMITED 2007-01-19 → present
2. ZLB BEHRING UK LIMITED 2004-07-20 → 2007-01-19
3. AVENTIS BEHRING LIMITED 2000-01-24 → 2004-07-20
4. CENTEON LIMITED 1996-01-02 → 2000-01-24
5. ARMOUR PHARMACEUTICAL COMPANY LIMITED 1982-06-23 → 1996-01-02
6. YEWAFT LIMITED 1982-03-16 → 1982-06-23

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Deloitte LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Company made a profit after tax in the year of £12,190,000 (2024: £11,162,000) and as at 30 June 2025 had cash at bank of £45,809,000 (2024: £28,705,000), net current assets of £82,642,000 (2024: £68,482,000) and net assets of £83,021,000 (2024: £68,933,000). The NHS decision to change two key products within the new NHS Supply Chain England framework agreement to reserve supplier status will significantly reduce revenues under the new contract. To counter this reduction in revenues a new product has been introduced within the year and a further one will follow next year. The directors are satisfied, based on current projections, that the Company has sufficient resources to meet its liabilities as they fall due for a period of at least 12 months from the date of signing these financial statements (Going concern assessment period) and accordingly the financial statement have been prepared on a going concern basis. CSL Limited, the ultimate parent undertaking, has indicated its intention to make available such funds, as may be needed, in the event that the Company is for some reason unable to meet its liabilities as they fall due in the going concern assessment period. As a result, the directors have obtained a letter of support from CSL Limited for the period from 12 months from the signing date. Accordingly, the directors continue to adopt the going concern basis in preparing the annual report and financial statements.”

Significant events

• “In December 2024, CSL Behring UK Ltd was notified of its reserve supplier status for two of its key products within the new NHS Supply Chain England framework agreement, effective from 1 April 2025. The combined revenue of the two products represents 74% of total revenue and this is expected to significantly reduce under the new contract.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +3.5%

  £253,708,000 → £262,515,000

• Cash

  +59.6%

  £28,705,000 → £45,809,000

• Net assets

  +20.4%

  £68,933,000 → £83,021,000

• Employees

  +14.8%

  61 → 70

• Operating profit

  +11.3%

  £14,847,000 → £16,518,000

• Profit before tax

  +10.9%

  £14,846,000 → £16,466,000

• Wages

  +35%

  £8,165,000 → £11,023,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers